Australian Clinical Labs Limited (AUCLINICAL FPO [ACL]) aksje
ACL.AX
AUCLINICAL FPO [ACL]
Market Cap
$375,344,800
Om Australian Clinical Labs Limited (AUCLINICAL FPO [ACL]) aksje
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Selskapsinformasjon
3168 Clayton, Australia
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.